Does EDOXABAN Cause Transfusion? 14 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Transfusion have been filed in association with EDOXABAN (SAVAYSA). This represents 0.2% of all adverse event reports for EDOXABAN.
14
Reports of Transfusion with EDOXABAN
0.2%
of all EDOXABAN reports
1
Deaths
12
Hospitalizations
How Dangerous Is Transfusion From EDOXABAN?
Of the 14 reports, 1 (7.1%) resulted in death, 12 (85.7%) required hospitalization, and 4 (28.6%) were considered life-threatening.
Is Transfusion Listed in the Official Label?
Yes, Transfusion is listed as a known adverse reaction in the official FDA drug label for EDOXABAN.
What Other Side Effects Does EDOXABAN Cause?
Anaemia (663)
Cerebral infarction (419)
Gastrointestinal haemorrhage (378)
Renal impairment (359)
Cerebrovascular accident (337)
Dyspnoea (331)
General physical health deterioration (315)
Haematuria (312)
Fall (298)
Cardiac failure (272)
What Other Drugs Cause Transfusion?
MACITENTAN (858)
VENETOCLAX (793)
APIXABAN (561)
ECULIZUMAB (454)
WARFARIN (377)
SELEXIPAG (289)
ADALIMUMAB (264)
AMBRISENTAN (244)
CEDAZURIDINE\DECITABINE (229)
EPOPROSTENOL (225)
Which EDOXABAN Alternatives Have Lower Transfusion Risk?
EDOXABAN vs EDOXABAN TOSILATE
EDOXABAN vs EFALIZUMAB
EDOXABAN vs EFANESOCTOCOG ALFA
EDOXABAN vs EFAVIRENZ
EDOXABAN vs EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL